Welcome to LookChem.com Sign In|Join Free
  • or
1-benzyl-3-(pyridin-3-yl)piperazine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

205059-22-9

Post Buying Request

205059-22-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

205059-22-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 205059-22-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,0,5 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 205059-22:
(8*2)+(7*0)+(6*5)+(5*0)+(4*5)+(3*9)+(2*2)+(1*2)=99
99 % 10 = 9
So 205059-22-9 is a valid CAS Registry Number.

205059-22-9Downstream Products

205059-22-9Relevant academic research and scientific papers

Visible-Light-Driven CarboxyLic Amine Protocol (CLAP) for the Synthesis of 2-Substituted Piperazines under Batch and Flow Conditions

Gueret, Robin,Pelinski, Lydie,Bousquet, Till,Sauthier, Mathieu,Ferey, Vincent,Bigot, Antony

, p. 5157 - 5162 (2020)

Piperazines are privileged scaffolds in medicinal chemistry. Disclosed herein is a visible-light-promoted decarboxylative annulation protocol between a glycine-based diamine and various aldehydes to access 2-aryl, 2-heteroaryl, as well as 2-alkyl piperazines. The iridium-based complex [Ir(ppy)2(dtbpy)]PF6 and carbazolyl dicyanobenzene 4CzIPN were found to be the photocatalysts of choice to efficiently perform the transformation under mild conditions, whether in batch or in continuous mode.

Modified amino acids, pharmaceuticals containing these compounds and method for their production

-

, (2008/06/13)

The present invention relates to modified amino acids of general formula wherein A, Z, X, n, m, R, R2, R3, R4 and R11 are defined as in claims 1 to 5, their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 205059-22-9